Shrimp allergy breakthrough? small study tests eating your way to tolerance
NCT ID NCT04552522
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a treatment called oral immunotherapy for people with shrimp allergy. 20 participants aged 12-40 with confirmed shrimp allergy were given increasing amounts of shrimp over time to see if they could tolerate more shrimp without a reaction. The main goal was to measure changes in the amount of shrimp that caused an allergic reaction after 12 months of treatment compared to simply avoiding shrimp.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20 people
The number who actually took part.
- Started
-
Aug 2020
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 12 - 40 years old * History of Immunoglobulin E-mediated shrimp allergy \> 3 episode/year or disturb quality of life * Positive oral food challenge test for shrimp Exclusion Criteria: * History of shrimp anaphylaxis (include cardiovascular or neurological symptoms) * Shellfish dependent exercise induced anaphylaxis * History of cardiovascular disease, uncontrolled asthma, severe atopic dermatitis * History of Beta-blocker, Angiotensin-converting enzyme inhibitor, Angiotensin receptor blocker, Calcium channel blocker
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Allergy to shrimp are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Siriraj Hospital
Bangkoknoi, Bangkok, 10700, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can precision radiation and immunotherapy team up against abdominal colorectal cancer?
- Can a Three-Dose immunotherapy cure early lung cancer without surgery?
- MRI 'Fingerprint' may reveal which head and neck tumors vanish with Pre-Surgery therapy
- A new tool aims to demystify immunotherapy for advanced cancer patients
- Can a Dual-Drug combo shrink lung tumors before surgery?
- Can adding radiation at the right time boost immunotherapy for aggressive lung cancer?